Showing results (221-230 of 812) with videos related to

Sort By:
Pageof 82
Endocrine, Metabolic & Immune Disorders Drug Targets|October 12, 2018
Effects of Polyphenol Administration to European Farmed Sea Bass (Dicentrharcus labrax L.): Special Focus on Hepatopancreas MorphologyThea Magrone, Anna Spagnoletta, Manrico Magrone, et al.
International Journal for Equity in Health|September 19, 2009
Temporal and geographic heterogeneity of the association between socioeconomic position and hospitalisation in Italy: an income based indicatorPatrizia Schifano, Chiara Marinacci, Giulia Cesaroni, et al.
Critical Reviews in Oncology/Hematology|April 16, 2021
Current treatment options for HER2-positive breast cancer patients with brain metastasesDaniele Galanti, Alessandro Inno, Maria La Vecchia, et al.
Current Medical Research and Opinion|May 19, 2005
Burden of illness in Italian patients with gastro-oesophageal reflux diseaseFranco Pacini, Carlo Calabrese, Livio Cipolletta, et al.
Movement Disorders Clinical Practice|January 11, 2021
Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID-19 OutbreakRosa De Micco, Mattia Siciliano, Valeria Sant'Elia, et al.
Frontiers in Cardiovascular Medicine|October 28, 2024
Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspectiveMatteo Antonio Russo, Matteo Puccetti, Claudio Costantini, et al.
International Journal of Molecular Sciences|August 12, 2023
Migraine Treatment: Towards New Pharmacological TargetsMarcello Silvestro, Luigi Francesco Iannone, Ilaria Orologio, et al.
Expert Review of Neurotherapeutics|January 30, 2025
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxisMichail Vikelis, Dimitrios Rikos, Andreas A Argyriou, et al.
Molecular Cancer|July 13, 2014
Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cellsSimona Taverna, Valeria Amodeo, Laura Saieva, et al.
Molecular Cancer|August 6, 2010
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repairMario Federico, Catherine E Symonds, Luigi Bagella, et al.
Pageof 82